1
|
Muretta JM, Rajasekaran D, Blat Y, Little S, Myers M, Nair C, Burdekin B, Yuen SL, Jimenez N, Guhathakurta P, Wilson A, Thompson AR, Surti N, Connors D, Chase P, Harden D, Barbieri CM, Adam L, Thomas DD. HTS driven by fluorescence lifetime detection of FRET identifies activators and inhibitors of cardiac myosin. SLAS Discov 2023; 28:223-232. [PMID: 37307989 PMCID: PMC10422832 DOI: 10.1016/j.slasd.2023.06.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/03/2022] [Revised: 05/08/2023] [Accepted: 06/07/2023] [Indexed: 06/14/2023]
Abstract
Small molecules that bind to allosteric sites on target proteins to alter protein function are highly sought in drug discovery. High-throughput screening (HTS) assays are needed to facilitate the direct discovery of allosterically active compounds. We have developed technology for high-throughput time-resolved fluorescence lifetime detection of fluorescence resonance energy transfer (FRET), which enables the detection of allosteric modulators by monitoring changes in protein structure. We tested this approach at the industrial scale by adapting an allosteric FRET sensor of cardiac myosin to high-throughput screening (HTS), based on technology provided by Photonic Pharma and the University of Minnesota, and then used the sensor to screen 1.6 million compounds in the HTS facility at Bristol Myers Squibb. The results identified allosteric activators and inhibitors of cardiac myosin that do not compete with ATP binding, demonstrating high potential for FLT-based drug discovery.
Collapse
Affiliation(s)
- J M Muretta
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America.
| | - D Rajasekaran
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - Y Blat
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - S Little
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - M Myers
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - C Nair
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - B Burdekin
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - S L Yuen
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - N Jimenez
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - P Guhathakurta
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - A Wilson
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - A R Thompson
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America
| | - N Surti
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - D Connors
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - P Chase
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - D Harden
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - C M Barbieri
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - L Adam
- Bristol Myers Squibb, Princeton, NJ, United States of America
| | - D D Thomas
- Photonic Pharma LLC and University of Minnesota, Minneapolis, MN, United States of America.
| |
Collapse
|
2
|
Greene S, Spertus JA, Tang W, Kang A, Zhong Y, Myers M, Shen S, Jiang J, Liu X, Steffen DR, Viola M, Felker GM. Heart failure across the range of preserved ejection fraction in United States clinical practice. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Recent clinical trials of heart failure with preserved ejection fraction (HFpEF) have observed varying patient profiles by ejection fraction (EF), with attenuation of treatment benefits as EF increases. In routine clinical practice, the degree to which patients hospitalized for HF with EF≥60% may differ from those with lower EF is unknown.
Purpose
To compare patient characteristics, treatment patterns, and clinical outcomes across the range of EF among patients hospitalized for HFpEF.
Methods
Using the Humedica electronic medical records database between Jan 2010 and Dec 2020, patients hospitalized for a primary diagnosis of HF with EF>40% and who were haemodynamically stable at admission, without concurrent acute coronary syndrome or end-stage renal disease, and treated with intravenous (IV) diuretic agents within 48 h of admission were identified. Patient characteristics, treatment patterns, and clinical outcomes were compared by EF ranges of 41–49%, 50–59%, and ≥60%.
Results
Of 47,026 patients hospitalized with HFpEF, 6,335 (13%) had EF 41–49%, 18,603 (40%) had EF 50–59%, and 22,088 (47%) had EF≥60%. Across all 3 groups, patients were similar with respect to age (median 77 years for each group), race (83–84% White, 12–13% Black), systolic blood pressure (137–138 mmHg at admission), and eGFR (63–64 mL/min/1.73 m2 at admission). With progressively higher EF group, the proportion of women increased (45% vs 54% vs 65%) and median NT-proBNP decreased (4,221 vs 2,945 vs 2,234 pg/mL). Patients with EF ≥60% had the lowest rates of coronary artery disease and atrial fibrillation, and the highest rates of chronic pulmonary disease (Figure 1, Panel A). Discharge medications were generally similar, with exception of less beta-blocker use and more calcium channel blocker use among those with EF ≥60% (Figure 1, Panel B). Discharge use of angiotensin receptor-neprilysin inhibitor and sodium glucose cotransporter-2 inhibitor therapies were each <1% in all groups. Hospital length of stay (median 4 days for each group) and in-hospital mortality (1.1–1.3%) were similar across groups, but rates of in-hospital acute respiratory failure were higher among patients with EF ≥60% (27% vs 230-25% for lower EF groups). Rates of 30-day and 12-month post-discharge clinical events were high irrespective of EF, without meaningful differences between groups (Figure 2).
Conclusion
In a contemporary real-world population of US patients hospitalized for HF with EF >40%, nearly half had an EF≥60%. While clinical profiles and discharge medications varied, post-discharge outcomes were similarly poor irrespective of EF. There remain important opportunities to improve the care and outcomes for patients with HF across the range of preserved ejection fraction.
Funding Acknowledgement
Type of funding sources: Private company. Main funding source(s): MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb
Collapse
Affiliation(s)
- S Greene
- Duke Clinical Research Institute , Durham , United States of America
| | - J A Spertus
- St. Luke's Mid America Heart Institute , Kansas City , United States of America
| | - W Tang
- Duke Clinical Research Institute , Durham , United States of America
| | - A Kang
- Bristol-Myers Squibb Company , Lawrenceville , United States of America
| | - Y Zhong
- Bristol-Myers Squibb Company , Lawrenceville , United States of America
| | - M Myers
- Bristol-Myers Squibb Company , Lawrenceville , United States of America
| | - S Shen
- Bristol-Myers Squibb Company , Lawrenceville , United States of America
| | - J Jiang
- Bristol-Myers Squibb Company , Lawrenceville , United States of America
| | - X Liu
- Bristol-Myers Squibb Company , Lawrenceville , United States of America
| | - D R Steffen
- Analysis Group Inc. , New York , United States of America
| | - M Viola
- Analysis Group Inc. , New York , United States of America
| | - G M Felker
- Duke Clinical Research Institute , Durham , United States of America
| |
Collapse
|
3
|
Fulford RS, Russell M, Myers M, Malish M, Delmaine A. Models help set ecosystem service baselines for restoration assessment. J Environ Manage 2022; 317:115411. [PMID: 35751248 DOI: 10.1016/j.jenvman.2022.115411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/24/2022] [Revised: 05/23/2022] [Accepted: 05/24/2022] [Indexed: 06/15/2023]
Abstract
Coastal suburban watersheds are under heavy pressure from human activity. This pressure has yielded an extensive effort to protect, mitigate, and restore watershed ecosystem services. Assessment of restoration investments would be greatly improved by a standard approach for estimating change in ecosystem service production combined with a well-defined baseline for assessment of restoration effects. Here we take a model-based approach to both objectives by applying two established ecosystem service models in a representative coastal watershed. This watershed has undergone extensive suburbanization resulting in a loss of ecosystem services, which has resulted in heavy restoration investments. We used models to estimate loss of the ecosystem services; clean air, clean water, stable climate, and water storage resulting from suburbanization. We then applied these model-based estimates as a baseline for assessment of restoration focusing on the appropriate restoration scale and considering downstream watershed impacts. The results suggest that losses of ecosystem services, such as flood water storage, from suburbanization have been extensive since 2001, but a comparison of restoration value suggests that restoration has been effective in recouping ecosystem services in some but not all local regions suggesting there are trade-offs to be made in these efforts. These benefits were most evident for the services of clean water and water storage. Models can inform decisions by clarifying what has been lost and estimating what can be regained through restoration action. The former sets a baseline for the latter and allows for a functional equivalency approach to assessment.
Collapse
Affiliation(s)
- R S Fulford
- U.S. Environmental Protection Agency, Office of Research and Development, USA.
| | - M Russell
- U.S. Environmental Protection Agency, Office of Research and Development, USA.
| | - M Myers
- U.S. Environmental Protection Agency, Office of Research and Development, USA.
| | - M Malish
- U.S. Environmental Protection Agency, Office of Research and Development, USA.
| | - A Delmaine
- U.S. Environmental Protection Agency, Office of Research and Development, USA.
| |
Collapse
|
4
|
Russo L, Giboyeaux K, Gilman J, Jordan B, Myers M, Schaeffer A, Urban K, Wong C. Food Insecurity Needs Dietitians: Dietitians F.I.N.D. a Way to Help More During the Covid Pandemic. J Acad Nutr Diet 2022. [DOI: 10.1016/j.jand.2022.06.172] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
5
|
Myers M, Russo L, Jordan B, Stella C. Embracing the Virtual Care Paradigm: Dietitians Preference and Increased Utilization of Telehealth. J Acad Nutr Diet 2022. [DOI: 10.1016/j.jand.2022.06.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
6
|
Romanello J, Myers M, Nico E, Sussman R, Marantidis J, Rubin R. Could Hormone Levels Impact the Severity of Clitoral Phimosis? J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.05.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Romanello J, Nico E, Myers M, Sussman R, Marantidis J, Rubin R. Lysis of Clitoral Adhesions Should be in the Scope of a Urologist's Care. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.05.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
8
|
Romanello J, Myers M, Nico E, Sussman R, Marantidis J, Rubin R. Clitoral Phimosis Should Have its own Diagnostic and Procedural Codes. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.05.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
9
|
Nico E, Romanello J, Myers M, Sussman R, Marantidis J, Rubin R. Improvement in the Ability to Orgasm after the Non-Surgical Lysis Procedure for Clitoral Adhesions. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.05.104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
10
|
Myers M, Romanello J, Nico E, Sussman R, Marantidis J, Rubin R. Patient Satisfaction and Efficacy of Non-Surgical Lysis of Clitoral Adhesions. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.05.131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
11
|
Alfi E, Kocijan T, Colliva A, Abdelaleem GHA, Shevchuk O, Vodret S, Myers M, Sickmann A, Zacchigna S. Is lumican responsible for the low angiogenetic potential of the adult mammalian heart? Cardiovasc Res 2022. [DOI: 10.1093/cvr/cvac066.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): AIRC
Introduction
Adult mammals fail to regenerate the myocardium after ischemic injury (1). Different strategies to achieve myocardial regeneration have been considered including reactivation of progenitor cell populations, cell replacement therapies, cell reprograming and molecules able to stimulate cardiomyocyte proliferation (2). None of these approaches has been so far successful. The supply of nutrients and oxygen to the myocardium after the occlusion of a coronary artery depends on pre-existing and newly formed collateral vessels (3). The relevance of revascularization in the context of cardiac regeneration is suggested by the evidence that angiogenesis precedes cardiomyocyte proliferation in a model of neonatal heart injury (4). Our laboratory has recently demonstrated that the heart has a low angiogenetic potential (5). To what extent this is responsible for the poor regenerative capacity of the heart remains to be determined. Thus, understanding the mechanisms blocking angiogenesis in the adult heart could lead to the development of efficient strategies to promote cardiac revascularization and regeneration.
Purpose
Our purpose is to understand the mechanisms responsible for the low angiogenic potential of the adult mammalian heart. In particular, we designed a proteomic approach to detect differences in the composition of the perivascular extracellular matrix between the neonatal (angiogenic) with and the adult (not angiogenic) heart.
Methods and Results
We adopted an in vivo biotinylation strategy to label vascular extracellular proteins in vivo, followed by protein identification by mass spectrometry. A reactive derivative of biotin was systemically injected in both neonatal and adult mice (n=4) to label vascular and peri-vascular extracellular proteins. Biotinylated proteins were purified from total hearts by streptavidin-conjugated beads, eluted, and digested with trypsin. The resulting peptides were analyzed by LC-MS/MS. Among the differentially expressed proteins, we identified lumican and its receptor, integrin beta-1. This ligand-receptor pair is known to impair tube formation by endothelial cells and to interfere with both expression and activity of matrix metalloproteinases (MMPs) in vitro (6). Western blot and gene expression analysis confirmed up-regulation of lumican in the adult compared to neonatal heart, as well as a different glycosylation pattern. Lumican knock-out both ex vivo and in vivo resulted in increased vessel density. On the other hand, overexpression of lumican impaired the proliferative capacity of cardiac endothelial cells. Finally, MMP-14 activity was inhibited by adult, but not neonatal cardiac extract.
Conclusions
In vivo proteomic analysis identified lumican as a major contributor of the low angiogenic potential of the adult mammalian heart. These results point to lumican silencing as a promising strategy to achieve cardiac revascularization.
Collapse
Affiliation(s)
- E Alfi
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| | - T Kocijan
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| | - A Colliva
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| | - GHA Abdelaleem
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| | - O Shevchuk
- Technical University of Dortmund , Dortmund , Germany
| | - S Vodret
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| | - M Myers
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| | - A Sickmann
- Technical University of Dortmund , Dortmund , Germany
| | - S Zacchigna
- International Centre for Genetic Engineering and Biotechnology (ICGEB) , Trieste , Italy
| |
Collapse
|
12
|
Kenny JÉS, Clarke G, Myers M, Elfarnawany M, Eibl AM, Eibl JK, Nalla B, Atoui R. A Wireless Wearable Doppler Ultrasound Detects Changing Stroke Volume: Proof-of-Principle Comparison with Trans-Esophageal Echocardiography during Coronary Bypass Surgery. Bioengineering (Basel) 2021; 8:203. [PMID: 34940356 PMCID: PMC8698882 DOI: 10.3390/bioengineering8120203] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2021] [Revised: 11/30/2021] [Accepted: 12/07/2021] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND A novel, wireless, ultrasound biosensor that adheres to the neck and measures real-time Doppler of the carotid artery may be a useful functional hemodynamic monitor. A unique experimental set-up during elective coronary artery bypass surgery is described as a means to compare the wearable Doppler to trans-esophageal echocardiography (TEE). METHODS A total of two representative patients were studied at baseline and during Trendelenburg position. Carotid Doppler spectra from the wearable ultrasound and TEE were synchronously captured. Areas under the receiver operator curve (AUROC) were performed to assess the accuracy of changing common carotid artery velocity time integral (ccVTI∆) at detecting a clinically significant change in stroke volume (SV∆). RESULTS Synchronously measuring and comparing Doppler spectra from the wearable ultrasound and TEE is feasible during Trendelenburg positioning. In two representative cardiac surgical patients, the ccVTI∆ accurately detected a clinically significant SV∆ with AUROCs of 0.89, 0.91, and 0.95 when single-beat, 3-consecutive beat and 10-consecutive beat averages were assessed, respectively. CONCLUSION In this proof-of-principle research communication, a wearable Doppler ultrasound system is successfully compared to TEE. Preliminary data suggests that the diagnostic accuracy of carotid Doppler ultrasonography at detecting clinically significant SV∆ is enhanced by averaging more cardiac cycles.
Collapse
Affiliation(s)
- Jon-Émile Stuart Kenny
- Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada; (G.C.); (A.M.E.); (J.K.E.); (B.N.); (R.A.)
- Flosonics Medical, 325 Front Street, Toronto, ON M5V 2Y1, Canada; (M.M.); (M.E.)
| | - Geoffrey Clarke
- Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada; (G.C.); (A.M.E.); (J.K.E.); (B.N.); (R.A.)
- Flosonics Medical, 325 Front Street, Toronto, ON M5V 2Y1, Canada; (M.M.); (M.E.)
| | - Matt Myers
- Flosonics Medical, 325 Front Street, Toronto, ON M5V 2Y1, Canada; (M.M.); (M.E.)
| | - Mai Elfarnawany
- Flosonics Medical, 325 Front Street, Toronto, ON M5V 2Y1, Canada; (M.M.); (M.E.)
| | - Andrew M. Eibl
- Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada; (G.C.); (A.M.E.); (J.K.E.); (B.N.); (R.A.)
- Flosonics Medical, 325 Front Street, Toronto, ON M5V 2Y1, Canada; (M.M.); (M.E.)
| | - Joseph K. Eibl
- Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada; (G.C.); (A.M.E.); (J.K.E.); (B.N.); (R.A.)
- Flosonics Medical, 325 Front Street, Toronto, ON M5V 2Y1, Canada; (M.M.); (M.E.)
- Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada
| | - Bhanu Nalla
- Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada; (G.C.); (A.M.E.); (J.K.E.); (B.N.); (R.A.)
- Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada
| | - Rony Atoui
- Health Sciences North Research Institute, Sudbury, ON P3E 2H2, Canada; (G.C.); (A.M.E.); (J.K.E.); (B.N.); (R.A.)
- Northern Ontario School of Medicine, Sudbury, ON P3E 2C6, Canada
| |
Collapse
|
13
|
Blagden S, Haris N, Boh Z, Kazmi F, Aroldi F, Myers M, Symeonides S, Plummer R. 566TiP A first-in-human study of NUC-7738, a ProTide transformation of 3’-deoxyadenosine, in patients with advanced solid tumours (NuTide:701). Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.1088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
14
|
Kenny JS, Elfarnawany M, Yang Z, Myers M, Eibl AM, Eibl JK, Taylor JL, Kim CH, Johnson BD. The Doppler shock index measured by a wearable ultrasound patch accurately detects moderate-to-severe central hypovolemia during lower body negative pressure. J Am Coll Emerg Physicians Open 2021; 2:e12533. [PMID: 34401869 PMCID: PMC8349221 DOI: 10.1002/emp2.12533] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 06/22/2021] [Accepted: 07/20/2021] [Indexed: 12/05/2022] Open
Abstract
OBJECTIVE Moderate-to-severe hemorrhage is a life-threatening condition, which is challenging to detect in a timely fashion using traditional vital signs because of the human body's robust physiologic compensatory mechanisms. Measuring and trending blood flow could improve diagnosis of clinically significant exsanguination. A lightweight, wireless, wearable Doppler ultrasound patch that captures and trends blood flow velocity could enhance hemorrhage detection. METHODS In 11 healthy volunteers undergoing simulated hemorrhage and resuscitation during graded lower body negative pressure (LBNP) and release, we studied the relationship between stroke volume (SV) and common carotid artery velocity time integral (VTI) and corrected flow time (FTc). We assessed the diagnostic accuracy of 2 variations of a novel metric, the Doppler shock index (ie, the DSIVTI and DSIFTc), at capturing moderate-to-severe central hypovolemia defined as a 30% reduction in SV. The DSIVTI and DSIFTc are calculated as the heart rate divided by either the VTI or FTc, respectively. RESULTS A total of 17,822 cardiac cycles were analyzed across 22 LBNP protocols. The average SV reduction to the lowest tolerated LBNP stage was 40%; there was no clinically significant fall in the mean arterial pressure. Correlations between changing SV and the common carotid artery VTI and FTc were strong (R 2 of 0.87, respectively) and concordant. The DSIVTI and DSIFTc accurately detected moderate-to-severe central hypovolemia with values for the area under the receiver operator curves of 0.96 and 0.97, respectively. CONCLUSION In a human model of hemorrhage and resuscitation, measures from a wearable Doppler ultrasound patch correlated strongly with SV and identified moderate-to-severe central hypovolemia with excellent diagnostic accuracy.
Collapse
Affiliation(s)
| | - Mai Elfarnawany
- Health Sciences North Research InstituteSudburyOntarioCanada
- Flosonics MedicalSudburyOntarioCanada
| | - Zhen Yang
- Health Sciences North Research InstituteSudburyOntarioCanada
- Flosonics MedicalSudburyOntarioCanada
| | - Matt Myers
- Health Sciences North Research InstituteSudburyOntarioCanada
- Flosonics MedicalSudburyOntarioCanada
| | - Andrew M. Eibl
- Health Sciences North Research InstituteSudburyOntarioCanada
| | - Joseph K. Eibl
- Health Sciences North Research InstituteSudburyOntarioCanada
- Northern Ontario School of MedicineSudburyOntarioCanada
| | - Jenna L. Taylor
- Human Integrative and Environmental Physiology LaboratoryDepartment of Cardiovascular DiseasesMayo ClinicRochesterMinnesotaUSA
| | - Chul Ho Kim
- Human Integrative and Environmental Physiology LaboratoryDepartment of Cardiovascular DiseasesMayo ClinicRochesterMinnesotaUSA
| | - Bruce D. Johnson
- Human Integrative and Environmental Physiology LaboratoryDepartment of Cardiovascular DiseasesMayo ClinicRochesterMinnesotaUSA
| |
Collapse
|
15
|
Ius F, Van Raemdonck D, Hartwig M, Bottiger B, Loor G, Daoud D, Wei Q, Villavicencio-Theoduloz M, Osho A, Chandrashekaran S, Machuca T, Neyrinck A, Toyoda Y, Kashem M, Huddleston S, Myers M, Sanchez P, Ryssel N, Warnecke G. Effect of Surgical Exposure on Outcomes in Lung Transplantation: Insight from the International Multicenter Extracorporeal Life Support (ECLS) in Lung Transplantation Registry. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.489] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
16
|
Villavicencio M, Kashem M, Loor G, Hartwig M, Bottinger B, Ius F, Daoud D, Warnecke G, Wei Q, Chandrashekaran S, Machuca T, Van Raemdonck D, Neyrinck A, Huddleston S, Myers M, Moonsamy P, Toyoda Y. Impact of Cold Ischemic Time on Morbidity and Mortality after Lung Transplantation. An Updated Analysis of the International Multicenter Extracorporeal Life Support in Lung Transplantation Registry. J Heart Lung Transplant 2021. [DOI: 10.1016/j.healun.2021.01.1896] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
17
|
Shorten RJ, Haslam S, Hurley MA, Rowbottom A, Myers M, Wilkinson P, Orr D. Seroprevalence of SARS-CoV-2 infection in healthcare workers in a large teaching hospital in the North West of England: a period prevalence survey. BMJ Open 2021; 11:e045384. [PMID: 33727275 PMCID: PMC7969758 DOI: 10.1136/bmjopen-2020-045384] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Abstract
OBJECTIVES Since its emergence in late 2019, SARS-CoV-2 has caused a global pandemic that has significantly challenged healthcare systems. Healthcare workers have previously been shown to have experienced higher rates of infection than the general population. We aimed to assess the extent of infection in staff working in our healthcare setting. DESIGN A retrospective analysis of antibody results, compared with staff demographic data, and exposure to patients with COVID-19 infection. SETTING A large teaching hospital in the North West of England. PARTICIPANTS 4474 staff in diverse clinical and non-patient facing roles who volunteered for SARS-CoV-2 antibody testing by the Roche Elecsys assay between 29 May and 4 July 2020. RESULTS Seroprevalence was 17.4%. Higher rates were seen in Asian/Asian British (OR 1.61, 95% CI 1.27 to 2.04) and Black/Black British (OR 2.08, 95% CI 1.25 to 3.45) staff. Staff working in any clinical location were more likely to be seropositive (OR 2.68, 95% 2.27 to 3.15). Staff were at an increased risk of seropositivity as the 'per 100 COVID-19 bed-days change' increased in the clinical area in which they worked (OR 1.12, 95% 1.10 to 1.14). Staff working in critical care were no more likely to have detectable antibodies than staff working in non-clinical areas. Symptoms compatible with COVID-19 were reported in 41.8% and antibodies were detected in 30.7% of these individuals. In staff who reported no symptoms, antibodies were detected in 7.7%. In all staff who had detectable antibodies, 25.2% reported no symptoms. CONCLUSIONS Staff working in clinical areas where patients with COVID-19 were nursed were more likely to have detectable antibodies. The relationship between seropositivity in healthcare workers and the increase in 'per 100 COVID-19 bed-days' of the area in which they worked, although statistically significant, was weak, suggesting other contributing factors to the risk profile. Of staff with detectable antibodies and therefore evidence of prior infection, a quarter self-reported that they had experienced no compatible symptoms. This has implications for potential unrecorded transmission in both staff and patients.
Collapse
Affiliation(s)
- Robert John Shorten
- Department of Microbiology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
- Centre for Clinical Microbiology, University College London, London, UK
| | - Shonagh Haslam
- Department of Clinical Biochemistry, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
| | - Margaret A Hurley
- Research Support Team, University of Central Lancashire, Preston, Lancashire, UK
| | - Anthony Rowbottom
- Department of Immunology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
| | - M Myers
- Department of Clinical Biochemistry, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
| | - Paul Wilkinson
- Department of Microbiology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
| | - David Orr
- Department of Microbiology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, Lancashire, UK
| |
Collapse
|
18
|
Cohen M, Perl H, Steffen E, Planer B, Kushnir A, Hudome S, Brown D, Myers M. Micro-premature infants in New Jersey show improved mortality and morbidity from 2000-2018. J Neonatal Perinatal Med 2021; 14:583-590. [PMID: 33843700 PMCID: PMC8673536 DOI: 10.3233/npm-200599] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Revised: 02/05/2021] [Accepted: 03/20/2021] [Indexed: 06/12/2023]
Abstract
BACKGROUND Micro-premature newborns, gestational age (GA) ≤ 25 weeks, have high rates of mortality and morbidity. Literature has shown improving outcomes for extremely low gestational age newborns (ELGANs) GA ≤ 29 weeks, but few studies have addressed outcomes of ELGANs ≤ 25 weeks. OBJECTIVE To evaluate the trends in outcomes for ELGANs born in New Jersey, from 2000 to 2018 and to compare two subgroups: GA 23 to 25 weeks (E1) and GA 26 to 29 weeks (E2). METHODS Thirteen NICUs in NJ submitted de-identified data. Outcomes for mortality and morbidity were calculated. RESULTS Data from 12,707 infants represents the majority of ELGANs born in NJ from 2000 to 2018. There were 3,957 in the E1 group and 8,750 in the E2 group. Mortality decreased significantly in both groups; E1, 43.2% to 30.2% and E2, 7.6% to 4.5% over the 19 years. The decline in E1 was significantly greater than in E2. Most morbidities also showed significant improvement over time in both groups. Survival without morbidity increased from 14.5% to 30.7% in E1s and 47.2% to 69.9% in E2s. Similar findings held for 501-750 and 751-1000g birth weight strata. CONCLUSIONS Significant declines in both mortality and morbidity have occurred in ELGANs over the last two decades. These rates of improvements for the more immature ELGANs of GA 230 to 256 weeks were greater than for the more mature group in several outcomes. While the rates of morbidity and mortality remain high, these results validate current efforts to support the micro-premature newborn.
Collapse
Affiliation(s)
- M. Cohen
- Department of Pediatrics, Children’s Hospital of New Jersey, Newark, NJ, USA
| | - H. Perl
- Joseph M. Sanzari Children’s Hospital, HUMC, Hackensack, NJ, USA
| | - E. Steffen
- Department of Pediatrics, Saint Barnabas Medical Center, Livingston, NJ, USA
| | - B. Planer
- Joseph M. Sanzari Children’s Hospital, HUMC, Hackensack, NJ, USA
| | - A. Kushnir
- Department of Pediatrics, Cooper Children’s Regional Hospital, Camden, NJ, USA
| | - S. Hudome
- Unterberg Children’s Hospital at Monmouth M.C., Long Branch, NJ, USA
| | - D. Brown
- Department of Pediatrics, Children’s Hospital of New Jersey, Newark, NJ, USA
| | - M. Myers
- Department of Pediatrics, Children’s Hospital of New Jersey, Newark, NJ, USA
| | | |
Collapse
|
19
|
Devireddy L, Liu Z, Screven R, Boxer L, Myers M. Effect of culture medium and cell size on functional heterogeneity of canine adipose-derived mesenchymal stromal cells. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
20
|
Woollard DC, Indyk HE, Angyal G, Borbon J, Chase W, Coors U, Davis P, Edwards M, Ellis C, Gore W, Gossard J, Hischenhuber C, Jagodic M, Kerr M, Kmec D, McMahow A, Myers M, Rajamohan R, Saito K, Sullivan D, Tsalkani N, Walker E, Welton K, Wo C, Zaugg S. Taurine Analysis in Milk and Infant Formulae by Liquid Chromatography: Collaborative Study. J AOAC Int 2020. [DOI: 10.1093/jaoac/80.4.860] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
Abstract
Abstract
A collaborative study was conducted on a liquid chromatographic (LC) method for determination of taurine in infant formula and milk powders. Twenty laboratories participated in the analysis of 8 blind duplicates over the range of approximately 3–60 mg/100 g sample. The method involved protein removal, conversion to the dansyl-derivative, and isocratic LC separation with UV and/or fluorescence detection. Following outlier treatment, overall mean RSDR has been estimated at 7.00% for sup. plemented products with a HORRAT value of 1.1. The poorer precision at endogenous levels establishes a lower limit of determination of about 5 mg/100 g. An overall mean RSDr:RSDR value of 0.7 for all products demonstrated acceptable performance.
Collapse
Affiliation(s)
- David C Woollard
- Ministry of Agriculture, Lynfield Food Services Centre, PO Box 41, Auckland, New Zealand
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Tu H, Xu C, Tong-Li C, Offin M, Razavi P, Schapira E, Namakydoust A, Lee A, Pavlakis N, Clarke S, Diakos C, Chan D, Myers M, Makhnin A, Jain H, Martinez A, Iqbal Z, Adamski A, Li H, Hernandez J, Watford S, Hosseini A, Shaffer T, Lim L, Li M, Drilon A, Ladanyi M, Arcila M, Rusch V, Jones D, Rudin C, Rimner A, Isbell J, Li B. P1.01-122 A Clinical Utility Study of Plasma DNA Next Generation Sequencing Guided Treatment of Uncommon Drivers in Advanced Non-Small-Cell Lung Cancers. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.837] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
22
|
Brown DM, Poucher ZA, Myers M, Graham JD, Cairney J. Sinister right-handedness provides Canadian-born Major League Baseball players with an offensive advantage: A further test of the hockey influence on batting hypothesis. PLoS One 2019; 14:e0221501. [PMID: 31465478 PMCID: PMC6715196 DOI: 10.1371/journal.pone.0221501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2019] [Accepted: 08/09/2019] [Indexed: 11/18/2022] Open
Abstract
Recent research has shown Major League Baseball (MLB) players that bat left-handed and throw right-handed, otherwise known as sinister right-handers, are more likely to have a career batting average (BA) of .299 or higher compared to players with other combinations of batting and throwing handedness. Moreover, possibly owing to early exposure to hockey, Canadian-born MLB players have an increased propensity to be sinister right-handers, however, it has yet to be determined whether this provides a relative offensive performance advantage compared to players born in other countries. Using the largest archival dataset of MLB statistics available, the present study examined the independent influence of batting (i.e., left, right, switch) and throwing (i.e., left, right) handedness combinations and country/region of origin (i.e., Canada, USA, Latin America, Asia, Other) on several indices of offensive performance including BA, slugging percentage (SLG), on-base plus slugging (OPS), on-base plus slugging plus (OPS+), home runs (HR), runs batted in (RBI), strikeouts (SO) and wins above replacement (WAR). Mediation models were also computed to examine whether birthplace influences offensive performance through handedness. Examination of all recorded MLB batters revealed that batting left, regardless of throwing handedness, confers an offensive performance advantage. Since the inception of the MLB, the relative proportion of Canadian-born sinister right-handers is at least two times greater than players from other regions, although being Canadian-born does not provide a direct offensive advantage. Rather, results showed evidence of a significant indirect effect in that being Canadian-born increases the odds of being a sinister right-hander and in turn leads to greater performance across each offensive performance statistic. Collectively, findings provide further support for the hockey influence on batting hypothesis and suggest this effect extends to offensive performance.
Collapse
Affiliation(s)
- Denver M. Brown
- Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, Ontario, Canada
- * E-mail:
| | - Zoe A. Poucher
- Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, Ontario, Canada
| | - Matt Myers
- Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada
| | - Jeffrey D. Graham
- Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada
| | - John Cairney
- Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, Ontario, Canada
- Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada
| |
Collapse
|
23
|
|
24
|
Perkins K, Myers M, Haslam S. Method evaluation of ascitic and pleural fluid analysis. Clin Chim Acta 2019. [DOI: 10.1016/j.cca.2019.03.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
25
|
Hall S, Myers M, Sadek A, Baxter M, Dare C, Griffith C, Shenouda E, Nader-Sepahi A. P87 Spinal fractures incurred by a fall from standing height. J Neurol Neurosurg Psychiatry 2019. [DOI: 10.1136/jnnp-2019-abn.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
ObjectivesFalls from standing are an important cause of vertebral fractures, particularly in the elderly. They are associated with significant morbidity and long-term mortality. The aim of this study was to determine the treatment and outcomes, in a single centre, of managing spinal fractures due to falls from standing height.DesignRetrospective case note review of patients with a fracture sustained due to a fall from standing (2011–2016 inclusive).Subjects229 patients with average age 76.6±14.5 years; 134 (58.5%) female.MethodsPatients were identified from the Trauma Audit and Research Network database. Case notes were reviewed for demographics, treatment details and outcome at 6 months post-admission.Results1408 patients were admitted with spinal fractures of which 229 (16.3%) sustained a fall from standing height. Two hundred and eighty-three fractures were identified in the 229 patients, which were distributed in the cervical (n=140), thoracic (n=65) and lumbar (n=78) spine. The average ISS score was 9.7±5.4. Twenty-three (10.0%) patients had either incomplete or complete spinal cord injury. Fifty-six (24.5%) patients underwent surgical intervention. Forty-three patients (18.7%) died within 6 months and increasing age and Charlson co-morbidity score were associated with higher mortality.ConclusionsFalls from standing comprise a large portion of the spinal service emergency workload. They are associated with a high 6 month mortality similar to other fragility fractures experienced by the elderly.
Collapse
|
26
|
Offin M, Myers M, Josyula S, Shen R, Borsu L, Tsui D, Riely G, Rudin C, Yu H, Li B, Arcila M. P1.01-75 Utility of cfDNA Testing for Acquired Resistance: The Memorial Sloan Kettering Experience with Plasma EGFR T790M Clinical Testing. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.631] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
27
|
Li B, Offin M, Hembrough T, Cecchi F, Shen R, Olah Z, Panora E, Myers M, Brzostowski E, Buonocore D, Ginsberg M, Rudin C, Kris M, Weitsman G, Barber P, Ng T, Ulaner G, Arcila M, Scaltriti M. P1.13-43 Molecular and Imaging Predictors of Response to Ado-Trastuzumab Emtansine in Patients with HER2 Mutant Lung Cancers: An Exploratory Phase 2 Trial. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.900] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
28
|
Myers M, Holcombe J, Overstreet T, Taylor S, Epker J, Espenan M, Hill B. C - 23Pain Catastrophizing and Its Relation to Psychological Distress and Cognitive Performance in a Chronic Pain Sample. Arch Clin Neuropsychol 2018. [DOI: 10.1093/arclin/acy061.176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
29
|
Taylor S, Aita S, Beach J, Holcombe J, Myers M, Boettcher A, Epker J, Hill B. C - 55Base Rates of Failed Performance Validity Tests in a Chronic Pain Sample. Arch Clin Neuropsychol 2018. [DOI: 10.1093/arclin/acy061.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
30
|
Holcombe J, Myers M, Elliott E, Hill B. B - 71Exploring the Effect of Trait Anxiety on Working Memory Intra-Individual Variability: A Response Time Distributional Analysis Approach. Arch Clin Neuropsychol 2018. [DOI: 10.1093/arclin/acy061.147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
31
|
Aboumatar H, Naqibuddin M, Chung S, Adebowale H, Bone L, Brown T, Cooper LA, Gurses AP, Knowlton A, Kurtz D, Piet L, Putcha N, Rand C, Roter D, Shattuck E, Sylvester C, Urteaga-Fuentes A, Wise R, Wolff JL, Yang T, Hibbard J, Howell E, Myers M, Shea K, Sullivan J, Syron L, Wang NY, Pronovost P. Better Respiratory Education and Treatment Help Empower (BREATHE) study: Methodology and baseline characteristics of a randomized controlled trial testing a transitional care program to improve patient-centered care delivery among chronic obstructive pulmonary disease patients. Contemp Clin Trials 2017; 62:159-167. [PMID: 28887069 DOI: 10.1016/j.cct.2017.08.018] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2017] [Revised: 08/23/2017] [Accepted: 08/25/2017] [Indexed: 11/15/2022]
Abstract
BACKGROUND Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of hospitalizations. Interventional studies focusing on the hospital-to-home transition for COPD patients are few. In the BREATHE (Better Respiratory Education and Treatment Help Empower) study, we developed and tested a patient and family-centered transitional care program that helps prepare hospitalized COPD patients and their family caregivers to manage COPD at home. METHODS In the study's initial phase, we co-developed the BREATHE transitional care program with COPD patients, family-caregivers, and stakeholders. The program offers tailored services to address individual patients' needs and priorities at the hospital and for 3months post discharge. We tested the program in a single-blinded RCT with 240 COPD patients who were randomized to receive the program or 'usual care'. Program participants were offered the opportunity to invite a family caregiver, if available, to enroll with them into the study. The primary outcomes were the combined number of COPD-related hospitalizations and Emergency Department (ED) visits per participant at 6months post discharge, and the change in health-related quality of life over the 6months study period. Other measures include 'all cause' hospitalizations and ED visits; patient activation; self-efficacy; and, self-care behaviors. DISCUSSION Unlike 1month transitional care programs that focus on patients' post-acute care needs, the BREATHE program helps hospitalized COPD patients manage the post discharge period as well as prepare them for long term self-management of COPD. If proven effective, this program may offer a timely solution for hospitals in their attempts to reduce COPD rehospitalizations.
Collapse
Affiliation(s)
- H Aboumatar
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States; Division of General Internal Medicine, Dept. of Medicine, Johns Hopkins University School of Medicine, United States; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, United States; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, United States.
| | - M Naqibuddin
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States
| | - S Chung
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States
| | - H Adebowale
- Johns Hopkins Bayview Medical Center, United States
| | - L Bone
- Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, United States; Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, United States
| | - T Brown
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States
| | - L A Cooper
- Division of General Internal Medicine, Dept. of Medicine, Johns Hopkins University School of Medicine, United States; Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, United States; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, United States
| | - A P Gurses
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States; Anesthesiology and Critical Care, The Johns Hopkins School of Medicine, United States; Division of Health Sciences Informatics, The Johns Hopkins School of Medicine, United States; Malone Center for Engineering in Healthcare, Whiting School of Engineering, Johns Hopkins University, United States
| | - A Knowlton
- Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, United States
| | - D Kurtz
- Johns Hopkins Bayview Medical Center, United States
| | - L Piet
- Johns Hopkins Bayview Medical Center, United States
| | - N Putcha
- Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, United States
| | - C Rand
- Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, United States
| | - D Roter
- Department of Health, Behavior, and Society, Bloomberg School of Public Health, Johns Hopkins University, United States; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, United States
| | - E Shattuck
- Patient Advocate/Co-investigator, BREATHE Project, United States
| | - C Sylvester
- Johns Hopkins Bayview Medical Center, United States
| | - A Urteaga-Fuentes
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States
| | - R Wise
- Pulmonary and Critical Care Medicine, The Johns Hopkins School of Medicine, United States
| | - J L Wolff
- Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, United States
| | - T Yang
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States
| | - J Hibbard
- Health Policy Research Group, University of Oregon
| | - E Howell
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States; Johns Hopkins Bayview Medical Center, United States
| | - M Myers
- Johns Hopkins Home Care Group, United States
| | - K Shea
- Johns Hopkins Bayview Medical Center, United States
| | | | - L Syron
- Johns Hopkins Home Care Group, United States
| | - Nae-Yuh Wang
- Division of General Internal Medicine, Dept. of Medicine, Johns Hopkins University School of Medicine, United States; Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, United States
| | - P Pronovost
- Armstrong Institute for Patient Safety and Quality, The Johns Hopkins School of Medicine, United States; Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, United States; Anesthesiology and Critical Care, The Johns Hopkins School of Medicine, United States
| | | |
Collapse
|
32
|
Myers M, Hill B, Joanning H, Shelley-Tremblay J. C-54Physiological and Cognitive Intra-individual Variability are Negatively Associated. Arch Clin Neuropsychol 2017. [DOI: 10.1093/arclin/acx076.221] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
33
|
Arble D, Flak J, Myers M, Sandoval D, Seeley R. 0090 A MOUSE MODEL OF SLEEP APNEA REVEALS A KEY ROLE FOR LEPTIN IN THE PATHOGENESIS OF DISORDERED BREATHING. Sleep 2017. [DOI: 10.1093/sleepj/zsx050.089] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
34
|
Burns PM, Myers M, Sethian JD, Wolford MF, Giuliani JL, Obenschain SP, Lehmberg RH, Searles S, Friedman M, Hegeler F, Jaynes R, Smilgys RV. Development of a Continuous Multi-Thousand Shot Electron Beam Pumped KrF Rep-Rate Laser for Fusion Energy. Fusion Science and Technology 2017. [DOI: 10.13182/fst07-a1528] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- P. M. Burns
- Research Support Instruments, Lanham, MD 20706
| | - M. Myers
- Plasma Physics Division, Naval Research Laboratory, Washington, D.C. 20375
| | - J. D. Sethian
- Plasma Physics Division, Naval Research Laboratory, Washington, D.C. 20375
| | - M. F. Wolford
- Plasma Physics Division, Naval Research Laboratory, Washington, D.C. 20375
| | - J. L. Giuliani
- Plasma Physics Division, Naval Research Laboratory, Washington, D.C. 20375
| | - S. P. Obenschain
- Plasma Physics Division, Naval Research Laboratory, Washington, D.C. 20375
| | | | - S. Searles
- Research Support Instruments, Lanham, MD 20706
| | - M. Friedman
- Commonwealth Technology, Inc., Alexandria, VA 22315
| | - F. Hegeler
- Commonwealth Technology, Inc., Alexandria, VA 22315
| | - R. Jaynes
- Science Applications International Corporation, McLean, VA 22102
| | - R. V. Smilgys
- Science Applications International Corporation, McLean, VA 22102
| |
Collapse
|
35
|
Stone A, Blakely C, Bochantin K, Krawczel PD, Myers M, Nolan DT, Petersson-Wolfe CS, Pighetti GM, Ward S, Bewley JM. 0761 Housing and demographic effects on somatic cell score in southeast United States dairies. J Anim Sci 2016. [DOI: 10.2527/jam2016-0761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
36
|
Yoder AM, Sorensen JA, Foster F, Myers M, Murphy D, Cook G, May J, Jenkins P. Selecting target populations for ROPS retrofit programs in Pennsylvania and Vermont. J Agric Saf Health 2014; 19:175-90. [PMID: 24400422 DOI: 10.13031/jash.19.10035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Agriculture has the highest injury and fatality rates when compared with other U.S. industries, and tractor overturns remain the leading cause of agricultural fatalities. Rollover protection structures (ROPS) are the only proven devices to protect a tractor operator in the event of an overturn. These devices are 99% effective when used with a seatbelt. Nearly 49% of tractors in the U.S. are not equipped with a ROPS. Interventions such as social marketing, community awareness campaigns, and financial incentives have been directed at encouraging farmers to install ROPS on their unprotected tractors. The purpose of this study was to conduct similar comparisons of ROPS protection and readiness to retrofit in different segments of the Vermont and Pennsylvania farm communities. A telephone survey was used to collect data on ROPS prevalence, farm demographic characteristics, and farmer's stage of change relative to installing ROPS on farm tractors. Our data provide new and unique information on the prevalence of ROPS-equipped tractors relative to commodity, farm size, and a variety of other demographic variables. Extrapolating from these data, the commodities studied account for roughly 162,072 tractors across the two states. Of these, 85,927 (53%) do not have ROPS. Of these unprotected tractors, 77,203 are in Pennsylvania and 8,724 are in Vermont. Our other two research questions dealt with the farmer's stage of change and possible ways to segment this population. The stage of change portion of our work demonstrates that most Pennsylvania and Vermont farmers are not contemplating ROPS retrofitting in the near future. Since no major differences were found in the stage of change, the number of unprotected tractors was examined for each of the commodity groups. In Pennsylvania, 29% of all unprotected tractors were found on cash crop farms. This trend was even more apparent on smaller farms than large farms. This led to the selection of smaller cash crop farms as the target audience for social marketing messages. In contrast, researchers in Vermont found a bimodal distribution of unprotected tractors. Of all the commodity groups surveyed in Vermont, vegetable and cash crop farmers were least likely to have even one protected tractor to use on the farm. Probably the most encouraging finding from this study is that over 85% of Pennsylvania farms and over 87% of Vermont farms surveyed had at least one tractor available that had ROPS protection. Of those farms, 25.5% of the Pennsylvania farms and 46% of the Vermont farms have ROPS on all of their tractors. Both of these findings were greater than the findings from a 2006 survey of New York State farms, which found that 75% of surveyed New York farms have ROPS on at least one tractor and 18% have ROPS on all tractors. Even with these encouraging data, the goal of 100% of tractors with ROPS is far from being met. There are still an estimated 90,000 unprotected tractors on Pennsylvania and Vermont farms, and these farm owners are currently unmotivated to install ROPS. However as demonstrated in New York State, it may be possible to use social marketing that combines persuasive messages and cost-sharing to persuade these farmers that ROPS are indeed important and accessible.
Collapse
Affiliation(s)
- A M Yoder
- Department of Environmental, Agricultural and Occupational Health, University of Nebraska Medical Center, Omaha, Nebraska 68198-4388, USA.
| | - J A Sorensen
- New York Center for Agricultural Medicine and Health, Northeast Center for Agricultural Health, Cooperstown, New York, USA
| | - F Foster
- New York Center for Agricultural Medicine and Health, Northeast Center for Agricultural Health, Cooperstown, New York, USA
| | - M Myers
- New York Center for Agricultural Medicine and Health, Northeast Center for Agricultural Health, Cooperstown, New York, USA
| | - D Murphy
- Department of Agricultural and Biological Engineering,The Pennsylvania State University, University Park, Pennsylvania, USA
| | - G Cook
- University of Vermont, Morrisville, Vermont, USA
| | - J May
- New York Center for Agricultural Medicine and Health, Northeast Center for Agricultural Health, Cooperstown, New York, USA
| | - P Jenkins
- New York Center for Agricultural Medicine and Health, Northeast Center for Agricultural Health, Cooperstown, New York, USA
| |
Collapse
|
37
|
Swenson C, Oostema A, Myers M, Kilian A, Close O, Peacock J, Jones J. Direct Medical Costs of Traumatic Lumbar Puncture in the Setting of Possible Subarachnoid Hemorrhage. Ann Emerg Med 2013. [DOI: 10.1016/j.annemergmed.2013.07.191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
38
|
Schuster J, Myers M, Rosu M, Mukhopadhyay N, Weiss E. Influence of Volumetric Change and Tumor Motion on Inter- and Intrafractional Positional Variations in Frameless Stereotactic Body Radiation Therapy (SBRT) of Lung Tumors. Int J Radiat Oncol Biol Phys 2012. [DOI: 10.1016/j.ijrobp.2012.07.2178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
39
|
Barss P, Hiscoe L, Myers M, Blackett H, Olsen K. Built environment safety: epidemiology of head and brain injury and fractures from stair falls in Canada. Inj Prev 2012. [DOI: 10.1136/injuryprev-2012-040590e.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
40
|
Swinamer S, Fox S, Chu M, Novick R, Quantz M, Myers M, Guo R, McKenzie N, Sy J, Kiaii B. 257 Eight Year Experience With Endoscopic Radial Artery Harvest At A Canadian Centre. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|
41
|
Blom K, Baker B, How M, Dai M, Abbey S, Myers M, Abramson B, Irvine J, Perkins N, Tobe S. 904 Hypertension Analysis of Stress Reduction Using Mindfulness Meditation and Yoga: Results From a Randomized Controlled Trial. Can J Cardiol 2012. [DOI: 10.1016/j.cjca.2012.07.744] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
42
|
Larochelle P, Kollmannsberger C, Feldman RD, Schiffrin EL, Poirier L, Patenaude F, Ruether D, Myers M, Bjarnason G. Hypertension management in patients with renal cell cancer treated with anti-angiogenic agents. ACTA ACUST UNITED AC 2012; 19:202-8. [PMID: 22876146 DOI: 10.3747/co.19.972] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Inhibitors of the vascular endothelial growth factor (vegf-is) signalling pathway have fundamentally changed the treatment of metastatic renal cell carcinoma (mrcc). Hypertension is one of the most common side effects of vegf-is and has been reported with almost every vegf-i used for treatment to date. The exact mechanism of vegf-i-induced hypertension appears complex and multifactorial, and it remains to be fully explained. No randomized clinical trials are available to guide the management of hypertension during vegf-i treatment in mrcc patients. The guiding principles suggested here summarize the consensus of opinions on the diagnosis and management of vegf-i-induced hypertension during treatment of mrcc obtained from an expert working group composed of 4 Canadian medical oncologists and 5 Canadian hypertension specialists. The Canadian Hypertension Education Program guidelines, available literature, and expert opinion were used to develop the guiding principles.
Collapse
Affiliation(s)
- P Larochelle
- Institut de recherches cliniques de Montréal, Montreal, QC
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Stefater MA, MacLennan AJ, Lee N, Patterson CM, Haller A, Sorrell J, Myers M, Woods SC, Seeley RJ. The anorectic effect of CNTF does not require action in leptin-responsive neurons. Endocrinology 2012; 153:2647-54. [PMID: 22518062 PMCID: PMC3359614 DOI: 10.1210/en.2012-1024] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Leptin resistance is a feature of obesity that poses a significant therapeutic challenge. Any treatment that is effective to reduce body weight in obese patients must overcome or circumvent leptin resistance, which promotes the maintenance of excess body fat in obese individuals. Ciliary neurotrophic factor (CNTF) is unique in its ability to reduce food intake and body weight in obese, leptin-resistant humans and rodents. Although attempts to use CNTF as an obesity therapy failed due to the development of neutralizing antibodies to the drug, efforts to understand mechanisms for CNTF's anorectic effects provide an opportunity to develop new drugs for leptin-resistant individuals. CNTF and leptin share several structural, anatomic, and signaling properties, but it is not understood whether or how the two cytokines might interact to affect energy balance. Here, we conditionally deleted the CNTF receptor (CNTFR) subunit, CNTFRα, in cells expressing leptin receptors. We found that CNTFR signaling in leptin-responsive neurons is not required for endogenous maintenance of energy balance and is not required for the anorectic response to exogenous administration of a CNTF agonist. These results indicate that despite anatomical overlap for CNTF and leptin action, CNTF appears to act within a distinct neuronal population to elicit its potent anorectic effect.
Collapse
Affiliation(s)
- M A Stefater
- Metabolic Diseases Institute, Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio 45237, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
44
|
|
45
|
Myers M, Li J, Artibee K, Peltier A. Evaluation of Dermal Myelinated Fibers in Diabetic Polyneuropathy (IN1-1.002). Neurology 2012. [DOI: 10.1212/wnl.78.1_meetingabstracts.in1-1.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
46
|
Kerr JB, Brogan L, Myers M, Hutt KJ, Mladenovska T, Ricardo S, Hamza K, Scott CL, Strasser A, Findlay JK. The primordial follicle reserve is not renewed after chemical or γ-irradiation mediated depletion. Reproduction 2012; 143:469-76. [PMID: 22301887 DOI: 10.1530/rep-11-0430] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Reports indicate that germ-line stem cells present in adult mice can rapidly generate new oocytes and contribute to the primordial follicle reserve following conditions of ovotoxic stress. We further investigated the hypothesis that adult mice have the capacity to generate new oocytes by monitoring primordial follicle numbers throughout postnatal life and following depletion of the primordial follicle reserve by exposure to doxorubicin (DXR), trichostatin A (TSA), or whole-body γ-irradiation. We show that primordial follicle number remains stable in adult C57BL/6 mice between the ages of 25 and 100 days. However, within 2 days of treatment with DXR or TSA, primordial follicle numbers had declined to 65 and 51% respectively (P<0.05-0.01 when compared to untreated controls), with no restoration of follicle numbers evident after 7 days for either treatment. Furthermore, ovaries from mice subjected to sterilizing doses of γ-irradiation (0.45 or 4.5 Gy) revealed complete ablation of all primordial follicles 5 days after treatment, with no indication of follicular renewal. We conclude that neo-folliculogenesis does not occur following chemical or γ-irradiation mediated depletion of the primordial follicle reserve.
Collapse
Affiliation(s)
- J B Kerr
- Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria 3800, Australia
| | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Chen C, Liu Y, Maruvada S, Myers M, Khismatullin D. Effect of ethanol injection on cavitation and heating of tissues exposed to high-intensity focused ultrasound. Phys Med Biol 2012; 57:937-61. [DOI: 10.1088/0031-9155/57/4/937] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
48
|
Myers M, Liebler DC. Abstract LB-331: Protein expression signatures of epidermal growth factor receptor inhibition. Cancer Res 2011. [DOI: 10.1158/1538-7445.am2011-lb-331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
We have applied standardized shotgun and multiple reaction monitoring (MRM) proteomic platforms to detect protein expression changes associated with epidermal growth factor receptor (EGFR) stimulation and inhibition in A431 carcinoma cells. These experiments compared proliferating, stimulated (30 nmol EGF, 4h) with cells co-treated with EGF and either cetuximab (10 μg/ml) or gefitinib (500 nmol). The analyses are done by shotgun proteomics with liquid chromatography-tandem mass spectrometry (LC-MS/MS), using isoelectric focusing of peptide mixtures, followed by reverse phase LC-MS/MS on a Thermo LTQ instrument. Protein inventories (≥2 peptides per protein at 5% peptide FDR) for each set were approximately 3800 proteins at < 3% protein FDR. Differential protein expression was estimated by comparison of spectral count data with a generalized linear modeling (GLM) approach. EGF stimulation induced expression changes in 148 proteins. Effects of the inhibitors on this “stimulation signature” were then determined by GLM comparisons of spectral count data for cetuximab- and gefitinib-treated cell proteomes. These analyses identified 13 proteins whose EGF-induced expression was reversed by both drugs, 15 proteins reversed by cetuximab and 57 proteins reversed by gefitinib. Targeted MRM analysis verified differential expression of the 13 proteins reversed by both drugs, which comprise an “EGF inhibition signature”. These include the transcription factors c-Jun and JunD and the cell cycle inhibitor Cip1, which were upregulated by EGF and the protein CCDC50, which was decreased by EGF. MRM analyses also identified EGF-induced protein expression changes that were selectively reversed by either cetuximab or gefitinib. Serum deprivation, rather than EGF stimulation may account for a subset of the 106 protein changes that were not reversed by inhibitors in EGF treated cells. Our analyses also identified 87 and 149 proteins that were not affected by EGF, yet were significantly altered by cetuximab and gefitinib, respectively. Activation of the EGFR axis is typically measured via the phosphorylation status of EGFR tyrosine kinase substrates and downstream targets, but these measurements are difficult to achieve in tissues due to the low abundance of phosphorylated protein forms and the challenge of preserving phosphorylation status during sample preparation. Protein expression changes directed by EGFR activation may provide more robust measures of EGFR activation and inhibition. Ongoing studies will test the hypothesis that an EGF inhibition signature provides an early index of therapeutic responses to EGFR-targeted cancer therapies. (Supported by NIH Grant U54CA126479)
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr LB-331. doi:10.1158/1538-7445.AM2011-LB-331
Collapse
|
49
|
Trikudanathan G, Myers M, Karasik M, Weiser JS. Education and imaging. Gastrointestinal: Successful obliteration of bleeding duodenal varices using band ligation. J Gastroenterol Hepatol 2011; 26:209. [PMID: 21175818 DOI: 10.1111/j.1440-1746.2010.06557.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Affiliation(s)
- G Trikudanathan
- Department of Internal Medicine, University of Connecticut Medical Center, Farmington, CT, USA
| | | | | | | |
Collapse
|
50
|
Nagasaka K, Pim D, Massimi P, Thomas M, Tomaić V, Subbaiah VK, Kranjec C, Nakagawa S, Yano T, Taketani Y, Myers M, Banks L. The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 2010; 29:5311-21. [PMID: 20622900 DOI: 10.1038/onc.2010.265] [Citation(s) in RCA: 68] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
The cell polarity regulator, human Scribble (hScrib), is a potential tumour suppressor whose loss is a frequent event in late-stage cancer development. Little is yet known about the mode of action of hScrib, although recent reports suggest its role in the regulation of cell signalling. In this study we show that hScrib is a direct regulator of extracellular signal-regulated kinase (ERK). In human keratinocytes, loss of hScrib results in elevated phospho-ERK levels and concomitant increased nuclear translocation of phospho-ERK. We also show that hScrib interacts with ERK through two well-conserved kinase interaction motif (KIM) docking sites, both of which are also required for ERK-induced phosphorylation of hScrib on two distinct residues. Although wild-type hScrib can downregulate activation of ERK and oncogenic Ras co-transforming activity, an hScrib mutant that lacks the carboxy terminal KIM docking site has no such effects. These results provide a clear mechanistic explanation of how hScrib can regulate ERK signalling and begin to explain how loss of hScrib during cancer development can contribute to disease progression.
Collapse
Affiliation(s)
- K Nagasaka
- International Centre for Genetic Engineering and Biotechnology, Area Science Park, Trieste, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|